Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Is Pfizer Stock A Buy As It Leaps Into The Red-Hot Weight-Loss Race?
11:43am, Thursday, 25'th May 2023
Is Pfizer stock a buy after the company unveiled promising weight-loss results for its diabetes pill? Is PFE stock a buy or a sell right now?
Pfizer wins full FDA approval for oral COVID therapy Paxlovid for adults at high risk of developing severe illness
11:31am, Thursday, 25'th May 2023
Pfizer Inc. PFE, -1.95% said Thursday it has received full Food and Drug Administration approval for its Paxlovid oral treatment for COVID-19 for use in adult patients with high risk of developing sev
Pfizer's Paxlovid Covid Pill Granted Full FDA Approval
11:12am, Thursday, 25'th May 2023
Pfizer had been seeking full FDA approval for its oral antiviral pill after its emergency authorization in December 2021.
FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
10:24am, Thursday, 25'th May 2023
Pfizer and the FDA view Paxlovid as an important complementary tool to vaccination that can help high-risk Americans manage their Covid infections.
U.S. FDA approves Pfizer's COVID antiviral pill
10:11am, Thursday, 25'th May 2023
The U.S. Food and Drug Administration on Thursday granted a full approval to Pfizer's Paxlovid, an oral antiviral COVID-19 treatment for adults at high risk of progression to severe disease.
Pfizer Has the Prescription for Higher Share Prices
07:01am, Thursday, 25'th May 2023
Pfizer Inc. NYSE: PFE released the results of a peer review study that sent shares up more than 5%. The study evaluated the company's GLP-1 receptor agonist, danuglipron.
US Debt-Ceiling Crisis Looms: How Will It Impact Medical Stocks?
10:57am, Wednesday, 24'th May 2023
The United States is facing a looming debt-ceiling crisis that could have disastrous consequences for the global economy. The debt ceiling, or debt limit, is the total amount the U.S. government is al
Worried About a Recession? 2 Safe Stocks to Buy Now
06:30am, Wednesday, 24'th May 2023
Pfizer's priorities include investing in its business and rewarding shareholders through dividend growth. McKesson has shifted its focus to its highest-growth and highest-margin businesses.
FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?
05:15am, Wednesday, 24'th May 2023
There isn't much overlap between Amgen's business and Horizons', but that isn't stopping the FTC from looking to block the deal. Pfizer has a strong oncology portfolio and is planning to acquire Seage
Pfizer's diabetes pill shows similar weight loss results as Ozempic
04:40am, Wednesday, 24'th May 2023
Pfizer's oral diabetes drug could join the lineup of sought-after drugs tackling weight loss. A recent study showed promising weight loss results in those with Type 2 diabetes.
Report of new COVID wave in China pushes shares of vaccine makers higher
05:32pm, Tuesday, 23'rd May 2023
Dr. Kavita Patel, fmr. White House health policy director, joins 'Fast Money' to discuss the latest reports of a possible uptick of COVID cases in China, the immunity situation in the country, and the
Pharma industry remains in 'early innings' of new weight loss drug boom, says Scott Gottlieb
03:26pm, Tuesday, 23'rd May 2023
Former FDA Commissioner and Pfizer Board Member Dr. Scott Gottlieb joins 'The Exchange' to discuss the Surgeon General's social media warning, new weight loss drugs coming to market, and the potential
Pfizer's (PFE) Oral Diabetes Drug Aids in Weight Loss, Stock Up
11:24am, Tuesday, 23'rd May 2023
Data from a phase II study published in JAMA showed that Pfizer's (PFE) danuglipron reduces glycated hemoglobin and fasting plasma glucose (at all doses) and body weight (at the highest doses) at week
The Important — And Overlooked — Caveat Behind Pfizer's Rival To Novo Nordisk In Diabetes
10:43am, Tuesday, 23'rd May 2023
It's the heyday of GLP-1 drugs, an analyst said Tuesday after Pfizer stock surged on the results of its study in patients with diabetes. The post The Important — And Overlooked — Caveat Behind Pfi
Efficacy of Pfizer's weight-loss drug 'inferior' to others on the market, says UBS's Colin Bristow
06:56pm, Monday, 22'nd May 2023
Colin Bristow, UBS managing director, joins 'Fast Money' to discuss Pfizer's weight-loss drug.
